Check nearby libraries
Buy this book
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Journalist Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell the story of Vertex's bold endurance and eventual success. The pharmaceutical business is America's toughest and one of its most profitable. It's riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's 25-year drive to deliver breakthrough medicines.--From publisher description.
Check nearby libraries
Buy this book
Previews available in: English
Showing 3 featured editions. View all 3 editions?
Edition | Availability |
---|---|
1
The antidote: inside the world of new pharma
2014, Simon & Schuster
in English
- First Simon & Schuster hardcover edition.
1451655665 9781451655667
|
eeee
|
2
The Antidote: Inside the World of New Pharma
Dec 23, 2014, Simon & Schuster
paperback
1451655673 9781451655674
|
zzzz
Libraries near you:
WorldCat
|
3
Antidote: Inside the World of New Pharma
2014, Simon & Schuster, Limited
in English
145165569X 9781451655698
|
aaaa
Libraries near you:
WorldCat
|
Community Reviews (0)
Feedback?History
- Created September 17, 2021
- 1 revision
Wikipedia citation
×CloseCopy and paste this code into your Wikipedia page. Need help?
September 17, 2021 | Created by ImportBot | Imported from Better World Books record |